Ginsenoside Rg1 can effectively control hyperglycemia induced by T2DM through antioxidant and anti-inflammatory mechanisms [18] and prevent cognitive dysfunction in T2DM mice by inhibiting the PLC-CN-NFAT1-signaling pathway [19]. Here, NFATC2 is linked to type 2 diabetes mellitus.